Drugs / MM(H)RVNS
last change Oct 2024 re-read 2 minutes ago

MM(H)RVNS

Developed for
measles
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05630846 Dec 2022 → Jun 2024 measles GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MM(H)RVNS ClinicalTrials.gov intervention name — accepted as the source's own label NCT05630846